Weisshaar E, Szepietowski JC, Dalgard FJ, et al.; European S2k guideline on chronic pruritus. Acta Derm Venereol. 2019;99(5):469-506.
Millington GWM, Collins A, Lovell CR, et al.; British Association of Dermatologists' guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018. Br J Dermatol. 2018;178(1):34-60.
Kini SP, DeLong LK, Veledar E, et al.; The impact of pruritus on quality of life: the skin equivalent of pain. Arch Dermatol. 2011;147(10):1153-1156.
Reamy BV, Bunt CW, Fletcher S. A diagnostic approach to pruritus. Am Fam Physician. 2011;84(2):195-202. Accessed August 5, 2021. https://www.aafp.org/afp/2011/0715/p195.html
Ständer S, Weisshaar E, Mettang T, et al.; Clinical classification of itch. Acta Derm Venereol. 2007;87(4):291-294.
Andrade A, Kuah CY, Martin-Lopez JE, et al.; Interventions for chronic pruritus of unknown origin. Cochrane Database Syst Rev. 2020;(1):CD013128.
Moses S. Pruritus. Am Fam Physician. 2003;68(6):1135-1142. Accessed July 30, 2021. https://www.aafp.org/afp/2003/0915/p1135.html
Dinulos JGH. Eczema and hand dermatitis. In: Habif's Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 7th ed. Elsevier; 2020:90–124.
Frazier W, Bhardwaj N. Atopic dermatitis: diagnosis and treatment. Am Fam Physician. 2020;101(10):590-598. Accessed August 4, 2021. https://www.aafp.org/afp/2020/0515/p590.html
Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus. N Engl J Med. 2013;368(17):1625-1634.
Dinulos JGH. Contact dermatitis and patch testing. In: Habif's Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 7th ed. Elsevier; 2020:125–148.
Dinulos JGH. Superficial fungal infections. In: Habif's Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 7th ed. Elsevier; 2020:483–524.
Dinulos JGH. Infestations and bites. In: Habif's Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 7th ed. Elsevier; 2020:571–630.
Gunning K, Kiraly B, Pippitt K. Lice and scabies: treatment update. Am Fam Physician. 2019;99(10):635-642. Accessed August 4, 2021. https://www.aafp.org/afp/2019/0515/p635.html
Samarasekera EJ, Sawyer L, Wonderling D, et al.; Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses. Br J Dermatol. 2013;168(5):954-967.
Dinulos JGH. Urticaria, angioedema, and pruritus. In: Habif's Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 7th ed. Elsevier; 2020:176–214.
Boccanfuso SM, Cosmet L, Volpe AR, et al.; Skin xerosis. Clinical report on the effect of a moisturizing soap bar. Cutis. 1978;21(5):703-707.
Dinulos JGH. Cutaneous manifestations of internal disease. In: Habif's Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 7th ed. Elsevier; 2020:990–1012.
Reich A, Ständer S, Szepietowski JC. Drug-induced pruritus: a review. Acta Derm Venereol. 2009;89(3):236-244.
Tandon P, Rowe BH, Vandermeer B, et al.; The efficacy and safety of bile acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus. Am J Gastroenterol. 2007;102(7):1528-1536.
Mayo MJ, Handem I, Saldana S, et al.; Sertraline as a first-line treatment for cholestatic pruritus. Hepatology. 2007;45(3):666-674.
Kong X, Kong Y, Zhang F, et al.; Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: a meta-analysis (a prisma-compliant study) [published correction appears in Medicine (Baltimore). 2017; 96(3): e6031]. Medicine (Baltimore). 2016;95(40):e4949.
Yosipovitch G, Sugeng MW, Chan YH, et al.; The effect of topically applied aspirin on localized circumscribed neurodermatitis. J Am Acad Dermatol. 2001;45(6):910-913.
Murray-Brown FL. Naltrexone for cholestatic itch: a systematic review. BMJ Support Palliat Care. 2021;11(2):217-225.
Matsuda KM, Sharma D, Schonfeld AR, et al.; Gabapentin and pregabalin for the treatment of chronic pruritus. J Am Acad Dermatol. 2016;75(3):619-625.e6.
Argoff CE, Katz N, Backonja M. Treatment of postherpetic neuralgia: a review of therapeutic options. J Pain Symptom Manage. 2004;28(4):396-411.
Foroutan N, Etminan A, Nikvarz N, et al.; Comparison of pregabalin with doxepin in the management of uremic pruritus: a randomized single blind clinical trial. Hemodial Int. 2017;21(1):63-71.
Zylicz Z, Smits C, Krajnik M. Paroxetine for pruritus in advanced cancer. J Pain Symptom Manage. 1998;16(2):121-124.
Makhlough A, Ala S, Haj-Heydari Z, et al.; Topical capsaicin therapy for uremic pruritus in patients on hemodialysis [published correction appears in Iran J Kidney Dis. 2010;4(3):273]. Iran J Kidney Dis. 2010;4(2):137-140.
Gunal AI, Ozalp G, Yoldas TK, et al.; Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant. 2004;19(12):3137-3139.
Naini AE, Harandi AA, Khanbabapour S, et al.; Gabapentin: a promising drug for the treatment of uremic pruritus. Saudi J Kidney Dis Transpl. 2007;18(3):378-381.
Haber R, Bachour J, Salloum A, et al.; Comparison of gabapentin and doxepin in the management of uremic pruritus: a randomized crossover clinical trial. Dermatol Ther. 2020;33(6):e14522.
Feng WW, Yuan B, Shen FY, et al.; Efficacy of uremic pruritus treatment in patients undergoing hemodialysis, a network meta-analysis for randomized clinical trials. Nephrol Ther. 2021;17(1):30-34.
Nasrollahi AR, Miladipour A, Ghanei E, et al.; Montelukast for treatment of refractory pruritus in patients on hemodialysis. Iran J Kidney Dis. 2007;1(2):73-77.
Pakfetrat M, Malekmakan L, Hashemi N, et al.; Sertraline can reduce uremic pruritus in hemodialysis patient: a double blind randomized clinical trial from Southern Iran. Hemodial Int. 2018;22(1):103-109.
Young TA, Patel TS, Camacho F, et al.; A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients. J Dermatolog Treat. 2009;20(2):76-81.
Mullol J, Bousquet J, Bachert C, et al.; Update on rupatadine in the management of allergic disorders. Allergy. 2015;70(suppl100):1-24.
Karppinen A, Brummer-Korvenkontio H, Reunala T, et al.; Rupatadine 10 mg in the treatment of immediate mosquito-bite allergy. J Eur Acad Dermatol Venereol. 2012;26(7):919-922.
Jaros J, Lio P. Low dose naltrexone in dermatology. J Drugs Dermatol. 2019;18(3):235-238.
Zhai H, Frisch S, Pelosi A, et al.; Antipruritic and thermal sensation effects of hydrocortisone creams in human skin. Skin Pharmacol Appl Skin Physiol. 2000;13(6):352-357.
Curto L, Carnero LI, López-Aventin D, et al.; Fast itch relief in an experimental model for methylprednisolone aceponate topical corticosteroid activity, based on allergic contact eczema to nickel sulphate. J Eur Acad Dermatol Venereol. 2014;28(10):1356-1362.
Ständer S, Schürmeyer-Horst F, Luger TA, et al.; Treatment of pruritic diseases with topical calcineurin inhibitors. Ther Clin Risk Manag. 2006;2(2):213-218.
Elmariah SB, Lerner EA. Topical therapies for pruritus. Semin Cutan Med Surg. 2011;30(2):118-126.
Shohrati M, Tajik A, Harandi AA, et al.; Comparison of hydroxyzine and doxepin in treatment of pruritus due to sulfur mustard. Skinmed. 2007;6(2):70-72.
Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol. 1995;131(12):1403-1408.
Legat FJ. The antipruritic effect of phototherapy. Front Med (Lausanne). 2018;5:333.
Lindh JD, Bradley M. Clinical effectiveness of moisturizers in atopic dermatitis and related disorders: a systematic review. Am J Clin Dermatol. 2015;16(5):341-359.
Yuan C, Wang XM, Guichard A, et al.; N-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients. Clin Interv Aging. 2014;9:1163-1169.
Ersser SJ, Latter S, Sibley A, et al.; Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev. 2007;(3):CD004054.